The Cancer Diagnostics Market is predicted to reach US$ ~317.9 billion by 2031 from US$ ~154.2 billion in 2020, and to grow at a CAGR of ~6.8% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Type (Tumor Biomarker Testing, Imaging, Biopsy, and Endoscopy), Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Cervical Cancer, Prostate Cancer, Liver Cancer, Pancreatic cancer, Melanoma, and Non-Hodgkin Lymphoma)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
General Electric Company, Abbott, BD., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen, and bioMérieux, Inc., among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2018 & 2019
2. Base Year - 2020
3. Forecasted Years - 2021 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Cancer Diagnostics Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Cancer Diagnostics Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Cancer Diagnostics Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Cancer Diagnostics Market - ANALYSIS & FORECAST, BY REGION
North America Cancer Diagnostics Market
1. North America Cancer Diagnostics Market, by Country
1. US
2. Canada
1. North America Cancer Diagnostics Market, by Product
2. North America Cancer Diagnostics Market, by Type
3. North America Cancer Diagnostics Market, by Gender
4. North America Cancer Diagnostics Market, by Sales Channel
3. Europe Cancer Diagnostics Market
1. Europe Cancer Diagnostics Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Cancer Diagnostics Market, by Product
3. Europe Cancer Diagnostics Market, by Type
4. Europe Cancer Diagnostics Market, by Gender
5. Europe Cancer Diagnostics Market, by Sales Channel
4. Asia Pacific Cancer Diagnostics Market
1. Asia Pacific Cancer Diagnostics Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Cancer Diagnostics Market, by product
3. Asia Pacific Cancer Diagnostics Market, by Type
4. Asia Pacific Cancer Diagnostics Market, by Gender
5. Asia Pacific Cancer Diagnostics Market, by Sales Channel
5. Rest of the World Cancer Diagnostics Market
1. Rest of the World Cancer Diagnostics Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Cancer Diagnostics Market, by Product
3. Rest of the World Cancer Diagnostics Market, by Type
4. Rest of the World Cancer Diagnostics Market, by Gender
5. Rest of the World Cancer Diagnostics Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 14
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
Market Overview
The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...
Market Overview
The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...
Market Overview
The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...
Market Overview
The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....
The Cancer-focused Genetic Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The In Vitro Diagnostics Analyzers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...